SY	O
17-1	O
DYNAMIC	O
REGULATION	B:C1157519
OF	O
REDOX	B:C0030012
REGULATING	B:C1451271
FACTOR	I:C1451271
APE1	I:C1451271
/	O
REF	B:C1451271
-1	I:C1451271
ON	O
THE	O
OXIDATIVE	B:C0242606
STRESS	I:C0242606
AND	O
VASCULAR	B:C0947751
INFLAMMATION	I:C0947751
.	O

Apurinic	B:C1451271
/	I:C1451271
apyrimidinic	I:C1451271
endonuclease	I:C1451271
1	I:C1451271
/	O
redox	B:C1451271
factor	I:C1451271
-	I:C1451271
1	I:C1451271
(	O
APE1	B:C1451271
/	O
Ref	B:C1451271
-	I:C1451271
1	I:C1451271
)	O
is	O
a	O
multifunctional	B:C0033684
protein	I:C0033684
that	O
plays	O
a	O
central	O
role	O
in	O
the	O
cellular	B:C1155291
response	I:C1155291
to	I:C1155291
DNA	I:C1155291
damage	I:C1155291
and	O
redox	B:C1655231
regulation	I:C1655231
against	O
oxidative	B:C0242606
stress	I:C0242606
.	O

APE1	B:C1451271
/	O
Ref	B:C1451271
-	I:C1451271
1	I:C1451271
is	O
essential	O
for	O
cellular	B:C0007620
survival	I:C0007620
and	O
embryonic	B:C0752350
lethal	I:C0752350
in	O
knockout	B:C0206745
mouse	I:C0206745
models	B:C0887965
.	O

Heterozygous	O
APE1	B:C1451271
/	O
Ref	B:C1451271
-	I:C1451271
1	I:C1451271
mice	I:C1451271
showed	O
impaired	B:C0010957
endothelium	B:C0014257
-	O
dependent	O
vasorelaxation	B:C0042401
,	O
reduced	O
vascular	B:C0005847
NO	B:C3810607
levels	I:C3810607
,	O
and	O
are	O
hypertensive	B:C0857121
.	O

APE1	B:C1451271
/	O
Ref	B:C1451271
-	I:C1451271
1	I:C1451271
reduces	O
intracellular	B:C0178719
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
production	O
by	O
negatively	B:C1151146
regulating	I:C1151146
the	I:C1151146
activity	I:C1151146
of	I:C1151146
the	I:C1151146
NADPH	I:C1151146
oxidase	I:C1151146
.	O

APE1	B:C1451271
/	O
Ref	B:C1451271
-	I:C1451271
1	I:C1451271
is	O
predominantly	O
localized	B:C0392752
in	O
the	O
nucleus	B:C0007610
;	O
however	O
,	O
its	O
subcellular	B:C0729605
localization	O
is	O
dynamically	B:C1327622
regulated	I:C1327622
.	O

Recently	O
,	O
it	O
was	O
shown	O
that	O
APE1	B:C1451271
/	O
Ref	B:C1451271
-	I:C1451271
1	I:C1451271
is	O
secreted	B:C1327616
in	O
response	B:C1521754
to	I:C1521754
hyperacetylation	I:C1521754
at	O
specific	O
lysine	B:C0024337
residues	I:C0024337
.	O

We	O
investigated	O
the	O
functions	B:C1527118
of	O
extracellular	B:C0521119
APE1	B:C1451271
/	O
Ref	B:C1451271
-	I:C1451271
1	I:C1451271
with	O
respect	O
to	O
leading	O
anti-inflammatory	B:C1148560
signaling	I:C1148560
in	O
TNF	B:C1456820
-α	I:C1456820
-	O
stimulated	O
endothelial	B:C0225336
cells	I:C0225336
in	O
response	B:C2612728
to	O
acetylation	B:C1521754
.	O

Trichostatin	B:C0077063
A	I:C0077063
(	O
Trichostatin	B:C0077063
A	I:C0077063
)	O
,	O
an	O
inhibitor	B:C1512474
of	I:C1512474
histone	I:C1512474
deacetylase	I:C1512474
,	O
considerably	O
suppressed	O
vascular	B:C0078056
cell	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
-	I:C0078056
1	I:C0078056
(	O
vascular	B:C0078056
cell	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
-	I:C0078056
1	I:C0078056
)	O
in	O
TNF	B:C1456820
-α	I:C1456820
-	O
stimulated	O
endothelial	B:C0225336
cells	I:C0225336
.	O

During	O
Trichostatin	B:C0077063

A	I:C0077063
-mediated	O
acetylation	B:C1521754
in	O
culture	B:C0430400
,	O
a	O
time	O
-	O
dependent	O
increase	O
in	O
secreted	B:C1327616
APE1	B:C1451271
/	O
Ref	B:C1451271
-	I:C1451271
1	I:C1451271
was	O
confirmed	B:C0750484
.	O

Recombinant	B:C0034861
human	B:C0140145
APE1	I:C0140145
/	O
Ref	B:C0140145
-	I:C0140145
1	I:C0140145
with	O
reducing	O
activity	O
induced	O
a	O
conformational	B:C0301641
change	I:C0301641
in	O
TNFR1	B:C0255808
by	O
thiol	B:C1151052
-	I:C1151052
disulfide	I:C1151052
exchange	I:C1151052
.	O

Following	O
treatment	B:C0087111
with	O
the	O
neutralizing	B:C0475463
anti-	O
APE1	B:C1451271
/	O
Ref	B:C1451271
-	I:C1451271
1	I:C1451271
antibody	B:C0003241
,	O
inflammatory	B:C0037083
signals	I:C0037083
via	O
the	O
binding	B:C1167622
of	O
TNF	B:C1456820
-α	I:C1456820
to	O
TNFR1	B:C0255808
were	O
remarkably	O
recovered	O
.	O

Furthermore	O
,	O
rh	B:C0034861
APE1	B:C1451271
/	O
Ref	B:C0140145
-	I:C0140145
1	I:C0140145
inhibited	O
IL	B:C0021753
-	I:C0021753
1	I:C0021753
β	I:C0021753
-	O
induced	O
vascular	B:C0078056
cell	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
-	I:C0078056
1	I:C0078056
expression	B:C1171362
in	O
endothelial	B:C0225336
cells	I:C0225336
,	O
and	O
it	O
inhibited	O
iNOS	B:C1533698
or	O
COX	B:C0387583
-	I:C0387583
2	I:C0387583
expression	B:C1171362
in	O
lipopolysaccharide	B:C0023810
-	O
stimulated	O
RAW	B:C4042840
264.7	I:C4042840
macrophage	I:C4042840
cells	I:C4042840
.	O

These	O
results	O
strongly	O
indicate	O
that	O
anti-inflammatory	O
effects	O
of	O
secreted	B:C1327616
APE1	B:C1451271
/	O
Ref	B:C1451271
-	I:C1451271
1	I:C1451271
and	O
its	O
property	O
of	O
secreted	B:C1327616
APE1	B:C1451271
/	O
Ref	B:C1451271
-	I:C1451271
1	I:C1451271
may	O
be	O
useful	O
as	O
a	O
therapeutic	O
biomolecule	O
in	O
cardiovascular	B:C0007222
disease	I:C0007222
.	O

